Endo International Notifies Vivus It Will End Its Commercial Supply And License Agreements Related To Avanafil

By: via Benzinga
Endo International plc (NASDAQ: ENDP) announced in an 8-K filing on Wednesday that it plans on terminating its commercial supply and ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.